| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | JoAnn C L Schuh | |
| P2860 | cites work | False leukemia–lymphoma cell lines: an update on over 500 cell lines | Q29303646 |
| Induction of Tumors in Mice by Genomic Hypomethylation | Q29618551 | ||
| Database resources of the National Center for Biotechnology | Q29618892 | ||
| Magnetic resonance imaging of gastric cancer in Tff1 knock-out mice | Q30310874 | ||
| Topical and intratumoral photodynamic therapy with 5-aminolevulinic acid in a subcutaneous murine mammary adenocarcinoma | Q30755618 | ||
| Multicolor deconvolution microscopy of thick biological specimens | Q30883484 | ||
| Mouse ENU mutagenesis | Q33724129 | ||
| Studying cancer in the mouse | Q33739250 | ||
| Modeling human lung cancer in mice: similarities and shortcomings | Q33739273 | ||
| Mouse models for colorectal cancer | Q33739279 | ||
| Modeling metastasis in the mouse | Q33739285 | ||
| Mouse models of prostate cancer | Q33739296 | ||
| Mouse liver tumorigenesis: models, mechanisms, and relevance to human disease | Q33750520 | ||
| Animal models of exocrine pancreatic cancer | Q34011656 | ||
| Complex trait analysis in the mouse: The strengths, the limitations and the promise yet to come | Q34090825 | ||
| Transgenic mouse models of human breast cancer | Q34130558 | ||
| Mouse models for sporadic cancer | Q34174319 | ||
| Unraveling human cancer in the mouse: recent refinements to modeling and analysis | Q34188976 | ||
| Production of knockout rats using ENU mutagenesis and a yeast-based screening assay | Q34198108 | ||
| Murine models for experimental therapy of pediatric solid tumors with poor prognosis | Q34210418 | ||
| Brain tumor animal models: importance and progress | Q34221559 | ||
| Experimental animal models in pancreatic carcinogenesis: lessons for human pancreatic cancer | Q34269063 | ||
| Primary lung tumors in mice as an aid for understanding, preventing, and treating human adenocarcinoma of the lung | Q34272164 | ||
| New animal models of hepatitis B and C. | Q34282823 | ||
| Genetically engineered mouse models of astrocytoma: GEMs in the rough? | Q34283779 | ||
| The genetics of pancreatic adenocarcinoma: a roadmap for a mouse model | Q34283792 | ||
| Humane endpoints and cancer research. | Q34288404 | ||
| Human-SCID mouse chimeric models for the evaluation of anti-cancer therapies | Q34295077 | ||
| Building 'validated' mouse models of human cancer | Q34430852 | ||
| Technologically advanced cancer modeling in mice | Q34493193 | ||
| Telomerase in cancer and aging | Q34498093 | ||
| Telomere shortening and cell fates in mouse models of neoplasia | Q34498197 | ||
| Altered DNA methylation: a secondary mechanism involved in carcinogenesis | Q34504084 | ||
| Cancer modeling in the modern era: progress and challenges | Q34520417 | ||
| Cancer as a complex genetic trait: tumor susceptibility in humans and mouse models | Q34520426 | ||
| Many ways to telomere dysfunction: in vivo studies using mouse models | Q34535647 | ||
| Conditional mouse models of sporadic cancer | Q34632032 | ||
| Modelling haematopoietic malignancies in the mouse and therapeutical implications | Q34658571 | ||
| Mouse models of prostate carcinogenesis. | Q34669710 | ||
| Hepatocarcinogenesis in hepatitis viral infection: lessons from transgenic mouse studies | Q34730208 | ||
| Modeling cancer in mice | Q34770630 | ||
| Matrix metalloproteinases and their role in pancreatic cancer: a review of preclinical studies and clinical trials | Q34776972 | ||
| Noninvasive assessment of tumor cell proliferation in animal models | Q34786154 | ||
| A mouse model of human oral-esophageal cancer | Q34796816 | ||
| Animal models for studying lung cancer and evaluating novel intervention strategies | Q35008693 | ||
| Pathology of mouse models of intestinal cancer: consensus report and recommendations | Q35075841 | ||
| The role of absorption, distribution, metabolism, excretion and toxicity in drug discovery | Q35137624 | ||
| Engineering cancer resistance in mice | Q35138160 | ||
| Screening for chemopreventive (anticarcinogenic) compounds in rodents | Q35322183 | ||
| Role of CD31/platelet endothelial cell adhesion molecule-1 expression in in vitro and in vivo growth and differentiation of human breast cancer cells. | Q35749239 | ||
| Optical imaging of cancer metastasis to bone marrow: a mouse model of minimal residual disease | Q35788829 | ||
| Pathway pathology: histological differences between ErbB/Ras and Wnt pathway transgenic mammary tumors | Q35789027 | ||
| Induction of ovarian cancer by defined multiple genetic changes in a mouse model system | Q36496578 | ||
| A metastatic nude-mouse model of human pancreatic cancer constructed orthotopically with histologically intact patient specimens | Q37070130 | ||
| Dietary restriction reduces angiogenesis and growth in an orthotopic mouse brain tumour model | Q37352779 | ||
| Transgenic mice that express the human multidrug-resistance gene in bone marrow enable a rapid identification of agents that reverse drug resistance | Q37375639 | ||
| Interspecies contamination of the KM3 cell line: implications for CD63 function in melanoma metastasis. | Q40648637 | ||
| Treatment of uterine leiomyosarcoma in a xenograft nude mouse model using high-intensity focused ultrasound: a potential treatment modality for recurrent pelvic disease | Q40705716 | ||
| Ovarian tumorigenesis in mice transgenic for murine inhibin alpha subunit promoter-driven Simian Virus 40 T-antigen: ontogeny, functional characteristics, and endocrine effects | Q40819830 | ||
| Importance of orthotopic implantation for human tumors as model systems: relevance to metastasis and invasion | Q40870166 | ||
| Transgenic mouse models for gonadal tumorigenesis | Q40977389 | ||
| Triple paraneoplastic syndrome of hypercalcemia, leukocytosis and cachexia in two human tumor xenografts in nude mice | Q41212282 | ||
| Immune-deficient SCID and NOD/SCID mice models as functional assays for studying normal and malignant human hematopoiesis | Q41627809 | ||
| Accelerated onset of uterine tumors in transgenic mice with aberrant expression of the estrogen receptor after neonatal exposure to diethylstilbestrol | Q42547776 | ||
| A urokinase-derived peptide (A6) increases survival of mice bearing orthotopically grown prostate cancer and reduces lymph node metastasis | Q42855032 | ||
| Higher antitumor activity of vinflunine than vinorelbine against an orthotopic murine model of transitional cell carcinoma of the bladder. | Q44243831 | ||
| Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification | Q44274699 | ||
| MicroPET imaging of prostate cancer in LNCAP-SR39TK-GFP mouse xenografts | Q44364523 | ||
| Immunobiology of heterotransplanted human tumors in nude mice | Q45241448 | ||
| Magnetic resonance imaging of patched heterozygous and xenografted mouse brain tumors | Q48294869 | ||
| Generation of mice from wild-type and targeted ES cells by nuclear cloning | Q48900052 | ||
| Conference summary: First International Workshop on Animal models of Prostate Cancer. | Q53353444 | ||
| New tools in therapeutic research--prostatic cancer and models. | Q53671417 | ||
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 53-66 | |
| P577 | publication date | 2004-03-01 | |
| P1433 | published in | Toxicologic Pathology | Q7830407 |
| P1476 | title | Trials, tribulations, and trends in tumor modeling in mice | |
| P478 | volume | 32 Suppl 1 |
| Q37694647 | A novel microfluidic model can mimic organ-specific metastasis of circulating tumor cells |
| Q34250295 | An improved syngeneic orthotopic murine model of human breast cancer progression |
| Q36093956 | Animal models for exploring the pharmacokinetics of breast cancer therapies |
| Q52915643 | Animal models of pancreatic cancer for drug research. |
| Q34507203 | Arresten, a collagen-derived angiogenesis inhibitor, suppresses invasion of squamous cell carcinoma. |
| Q92989877 | Biomaterials to model and measure epithelial cancers |
| Q37139742 | Blood flow responses to mild-intensity exercise in ectopic vs. orthotopic prostate tumors; dependence upon host tissue hemodynamics and vascular reactivity |
| Q36332973 | CCL2/CCR2 chemokine signaling coordinates survival and motility of breast cancer cells through Smad3 protein- and p42/44 mitogen-activated protein kinase (MAPK)-dependent mechanisms |
| Q37984855 | Canine tumors: a spontaneous animal model of human carcinogenesis |
| Q38957233 | Caveolin-1 is a risk factor for postsurgery metastasis in preclinical melanoma models |
| Q49280135 | Comparative oncology: Integrating human and veterinary medicine |
| Q92859289 | Does the mouse tail vein injection method provide a good model of lung cancer? |
| Q53418683 | Establishment of a murine breast tumor model by subcutaneous or orthotopic implantation. |
| Q39140376 | Evaluation of a reductively activated duocarmycin prodrug against murine and human solid cancers |
| Q90620618 | Factors Affecting Growth Kinetics and Spontaneous Metastasis in the B16F10 Syngeneic Murine Melanoma Model |
| Q47283164 | First-In-Human Phase 1 CRISPR Gene Editing Cancer Trials: Are We Ready? |
| Q35687753 | Human tissue in the evaluation of safety and efficacy of new medicines: a viable alternative to animal models? |
| Q57826813 | Image-Based Profiling of Patient-Derived Pancreatic Tumor-Stromal Cell Interactions Within a Micropatterned Tumor Model |
| Q37127936 | Is tail vein injection a relevant breast cancer lung metastasis model? |
| Q27000792 | Lost in translation: animal models and clinical trials in cancer treatment |
| Q92888820 | Microfabricated Physiological Models for In Vitro Drug Screening Applications |
| Q37816111 | Modeling opportunities in comparative oncology for drug development |
| Q24673595 | Murine models to evaluate novel and conventional therapeutic strategies for cancer |
| Q37408533 | Near-infrared bioluminescent proteins for two-color multimodal imaging |
| Q36875703 | Resection of the primary tumor improves survival in metastatic breast cancer by reducing overall tumor burden. |
| Q92136282 | The role of mouse models in colorectal cancer research-The need and the importance of the orthotopic models |
| Q34295127 | Trypsin-2 enhances carcinoma invasion by processing tight junctions and activating ProMT1-MMP. |
| Q26822856 | Use of rodents as models of human diseases |
Search more.